-
Product Insights
NewNet Present Value Model: Verastem Inc’s VS-6766
Empower your strategies with our Net Present Value Model: Verastem Inc's VS-6766 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VS-01 in Ascites
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VS-01 in Ascites report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VS-01 in Ascites Drug Details: VS-01 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VS-105 in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VS-105 in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VS-105 in Chronic Kidney Disease (Chronic Renal Failure)...
-
Sector Analysis
NewAngola Beverages Consumption Trends and Forecasts Tracker, Q4 2023
Angola Beverages Market Report Overview The Angola beverages market size was 593.9 million liters (ML) in Q4 2023. The Angola beverages market research report offers comprehensive consumption volume data across several beverage categories for Q4 2023. Furthermore, the report precisely lists new product launches and highlights the latest beverage industry performance and developments every quarter. Buy the Full Report for More Insights on the Angola Beverages Market Forecast, Download a Free Sample Report
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defactinib Hydrochloride in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defactinib Hydrochloride in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defactinib Hydrochloride in Fallopian Tube Cancer Drug Details: Defactinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defactinib Hydrochloride in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defactinib Hydrochloride in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defactinib Hydrochloride in Peritoneal Cancer Drug Details: Defactinib hydrochloride (VS-6063)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defactinib Hydrochloride in Metastatic Uveal Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defactinib Hydrochloride in Metastatic Uveal Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defactinib Hydrochloride in Metastatic Uveal Melanoma Drug Details: Defactinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defactinib Hydrochloride in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defactinib Hydrochloride in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defactinib Hydrochloride in Colorectal Cancer Drug Details: Defactinib hydrochloride (VS-6063) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defactinib Hydrochloride in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defactinib Hydrochloride in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defactinib Hydrochloride in Ovarian Cancer Drug Details: Defactinib hydrochloride (VS-6063)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defactinib Hydrochloride in Malignant Pleural Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defactinib Hydrochloride in Malignant Pleural Mesothelioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defactinib Hydrochloride in Malignant Pleural Mesothelioma Drug Details: Defactinib hydrochloride...